Why the study?
The relationship between hepatorenal dysfunction severity assessed by the MELD-XI score and long-term clinical outcomes in heart failure patients receiving CRT had not been evaluated.
Does a higher MELD-XI score predict all-cause mortality in heart failure patients undergoing cardiac resynchronization therapy?
Does a higher MELD-XI score predict all-cause mortality in heart failure patients undergoing cardiac resynchronization therapy?
The MELD-XI score provides valuable prognostic information for risk stratification in heart failure patients undergoing CRT, with higher scores predicting lower CRT response and higher all-cause mortality.
May inform risk stratification in CRT recipients; leaves open prospective validation before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: